Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

Althea Technologies Announces Installation of a High-Speed Prefilled Syringe Line

By Pharmaceutical Processing | October 19, 2010

Althea Technologies, Inc., a  provider of
development and manufacturing services for biopharmaceuticals and
parenteral drug products, has completed the
installation of a new INOVA H3-5 high-speed syringe filling line.  This
line is located in Althea’s large scale & commercial manufacturing
facility in San Diego.

The expanded
capacity complements existing prefilled syringe manufacturing for
clinical supplies and allows Althea to provide its clients with drug
product in prefilled syringes from early development through commercial
supply.

The INOVA H3-5 syringe line operates within a Restricted Access
Barrier System (RABS) and incorporates the ability to fill under vacuum,
which facilitates handling of viscous products and products that
require minimal head space.  The line accommodates nested syringes from a
variety of suppliers and can produce batch sizes in excess of 100,000
units.  The system incorporates non-destructive, in-process weight
checks to minimize product loss.  Rick Hancock, President of Contract
Manufacturing Services at Althea Technologies, commented, “We’ve been
filling syringes for clinical use for over eight years, and the addition
of this new line allows us to continue to meet client requirements as
they progress from late stage development through commercialization.”

The prefilled syringe market is rapidly expanding as it provides
numerous benefits relating to patient compliance and product
differentiation.  “With our existing expertise in formulation
development and protein analytics, we can now offer clients an
integrated solution to quickly develop, register, and launch their
products in prefilled syringes,” added Dr. Shabbir Anik, CEO of Althea Technologies.

The line will be available for production of GMP batches in Q1, 2011.

Related Articles Read More >

Astellas
Astellas to spend $70M on new biotech campus in South San Francisco
Rainin
Mettler Toledo Rainin expands facilities in Vacaville, California
Elemental Machines
Elemental Machines aims to enlist lab freezers in fight against climate change 
Pfizer logo
Pfizer seeks to comply with voluntary Net-Zero Standard by 2040

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards